OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure

por Lo, Joan, Grimsrud, Christopher, Ott, Susan, Chandra, Malini, Hui, Rita, Sanchez, Gabriela, Gonzalez, Joel, Ettinger, Bruce
Publicado 2019

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years

por Lo, Joan C., Neugebauer, Romain S., Ettinger, Bruce, Chandra, Malini, Hui, Rita L., Ott, Susan M., Grimsrud, Christopher D., Izano, Monika A.
Publicado 2020

Determinants of Oral Bisphosphonate Use Beyond 5 Years

por Izano, Monika A., Lo, Joan C., Ettinger, Bruce, Ott, Susan M., Li, Bonnie H., Niu, Fang, Hui, Rita L., Neugebauer, Romain, Adams, Annette L.
Publicado 2020

Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women

por Izano, Monika A., Lo, Joan C., Adams, Annette L., Ettinger, Bruce, Ott, Susan M., Chandra, Malini, Hui, Rita L., Niu, Fang, Li, Bonnie H., Neugebauer, Romain S.
Publicado 2020